Regresa al Registro Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorNapolitano, Stefania
dc.contributor.authorMatrone, Nunzia
dc.contributor.authorMuddassir, A. L.
dc.contributor.authorMartini, Giulia
dc.contributor.authorSorokin, A.
dc.contributor.authorDe Falco, Vincenzo
dc.date.accessioned2021-04-20T09:42:10Z
dc.date.available2021-04-20T09:42:10Z
dc.date.issued2019-12-16
dc.identifier.citationNapolitano S, Matrone N, Muddassir AL, Martini G, Sorokin A, De Falco V, et al. Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression. J Exp Clin Cancer Res. 2019 Dec 16;38(1):492.
dc.identifier.issn1756-9966
dc.identifier.urihttps://hdl.handle.net/11351/5877
dc.descriptionCáncer colorrectal; Resistencia a inhibidores de MEK; Inhibidores de PD-L1
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofseriesJournal of Experimental & Clinical Cancer Research;38(1)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectRecte - Càncer
dc.subjectCòlon - Càncer
dc.subjectResistència als medicaments
dc.subject.meshColorectal Neoplasms
dc.subject.mesh/genetics
dc.subject.meshDrug Resistance, Neoplasm
dc.titleTriple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s13046-019-1497-0
dc.subject.decsneoplasias colorrectales
dc.subject.decs/genética
dc.subject.decsresistencia a los antineoplásicos
dc.relation.publishversionhttps://jeccr.biomedcentral.com/articles/10.1186/s13046-019-1497-0
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Napolitano S] Medical Oncology Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80100 Naples, Italy. Department of Gastrointestinal Medical Oncology, Division of Cancer Medicin0065, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. [Matrone N] Medical Oncology Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80100 Naples, Italy. Medical University of Vienna, Institute for Cancer Research, Borschkegasse 8A, 1090 Wien, Austria. [Muddassir AL, Sorokin A] Department of Gastrointestinal Medical Oncology, Division of Cancer Medicin0065, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. [Martini G] Medical Oncology Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80100 Naples, Italy. Gastrointestinal and neuroendocrine tumor group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [De Falco V] Medical Oncology Department of Precision Medicine, University of Campania “Luigi Vanvitelli”, 80100 Naples, Italy
dc.identifier.pmid31842958
dc.identifier.wos000510641700001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Regresa al Registro Simple